Skip to main content

Table 1 Comparison of IPNB patients with intrahepatic and extrahepatic lesions

From: Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study

 

Lesion location

P

Intrahepatic (n = 21)

Extrahepatic (n = 22)

Male/female (n)

10/11

11/11

0.876

Age (years)

62 (59–68)

63 (50.3–71.3)

0.884

BMI (kg/m2)

23.8 ± 3.4

24.9 ± 3.5

0.312

Symptoms (n)

 Abdominal pain

10

8

0.455

 Jaundice

11

15

0.289

 Fever

11

6

0.092

Imaging features (n)

 Choledocholithiasis

4

2

0.412

 Hepatolithiasis

5

0

0.021

 Biliary dilatation

21

19

0.233

 Intraluminal mass

6

14

0.021

 Biliary stricture

4

5

1.000

 Biliary wall thickening

2

7

0.132

Abnormal liver function (n)

9

15

0.095

Abnormal bilirubin (n)

4

15

0.001

CEA > 5 µg/L (n)

5

5

1.000

CA19-9 > 34 U/mL (n)

10

16

0.092

Operation time (min)

226.5 ± 75.3

317.2 ± 93.2

0.002

Patients without surgery (n)

1

4

0.345

Dysplasia / invasive carcinoma (n)

10/11

10/12

0.887

Positive margin (n)

3

2

0.664

Survival (n)

8

9

0.850

Survival without tumor (n)

7

8

0.835

  1. IPNB intraductal papillary neoplasm of the bile duct, BMI body mass index, CEA carcino-embryonic antigen, CA19-9 carbohydrate antigen 19–9